2008. Our Experiences with Erlotinib in Second and Third Line Treatment Patients with Advanced Stage Iiib/ Iv Non-Small Cell Lung Cancer. Biomolecules and Biomedicine. 8, 4 (Nov. 2008), 386–390. DOI:https://doi.org/10.17305/bjbms.2008.2905.